Schumacher M - Search Results

1

Mediators of the improvement in heart failure outcomes with empagliflozin in the EMPA-REG OUTCOME trial.

Fitchett D, Inzucchi SE, Zinman B, Wanner C, Schumacher M, Schmoor C, Ohneberg K, Ofstad AP, Salsali A, George JT, Hantel S, Bluhmki E, Lachin JM, Zannad F. Fitchett D, et al. Among authors: schumacher m. ESC Heart Fail. 2021 Dec;8(6):4517-4527. doi: 10.1002/ehf2.13615. Epub 2021 Oct 4. ESC Heart Fail. 2021. PMID: 34605192 Free PMC article.

2

Sample sizes for clinical trials with time-to-event endpoints and competing risks.

Schulgen G, Olschewski M, Krane V, Wanner C, Ruf G, Schumacher M. Schulgen G, et al. Among authors: schumacher m. Contemp Clin Trials. 2005 Jun;26(3):386-96. doi: 10.1016/j.cct.2005.01.010. Epub 2005 Apr 26. Contemp Clin Trials. 2005. PMID: 15911472

3

Evidence from nonrandomized studies: a case study on the estimation of causal effects.

Schmoor C, Caputo A, Schumacher M. Schmoor C, et al. Among authors: schumacher m. Am J Epidemiol. 2008 May 1;167(9):1120-9. doi: 10.1093/aje/kwn010. Epub 2008 Mar 11. Am J Epidemiol. 2008. PMID: 18334500

4

Estimators and confidence intervals for the marginal odds ratio using logistic regression and propensity score stratification.

Stampf S, Graf E, Schmoor C, Schumacher M. Stampf S, et al. Among authors: schumacher m. Stat Med. 2010 Mar 30;29(7-8):760-9. doi: 10.1002/sim.3811. Stat Med. 2010. PMID: 20213703

5

Competing risks and multistate models.

Schmoor C, Schumacher M, Finke J, Beyersmann J. Schmoor C, et al. Among authors: schumacher m. Clin Cancer Res. 2013 Jan 1;19(1):12-21. doi: 10.1158/1078-0432.CCR-12-1619. Epub 2012 Nov 21. Clin Cancer Res. 2013. PMID: 23172882

6

Cardiovascular Risk Factors in Central Retinal Artery Occlusion: Results of a Prospective and Standardized Medical Examination.

Callizo J, Feltgen N, Pantenburg S, Wolf A, Neubauer AS, Jurklies B, Wachter R, Schmoor C, Schumacher M, Junker B, Pielen A; European Assessment Group for Lysis in the Eye. Callizo J, et al. Among authors: schumacher m. Ophthalmology. 2015 Sep;122(9):1881-8. doi: 10.1016/j.ophtha.2015.05.044. Epub 2015 Jul 21. Ophthalmology. 2015. PMID: 26231133 Clinical Trial.

7

Predictors of prognosis and treatment outcome in central retinal artery occlusion: local intra-arterial fibrinolysis vs. conservative treatment.

Pielen A, Pantenburg S, Schmoor C, Schumacher M, Feltgen N, Junker B, Callizo J; EAGLE Study Group. Pielen A, et al. Among authors: schumacher m. Neuroradiology. 2015 Oct;57(10):1055-62. doi: 10.1007/s00234-015-1588-3. Epub 2015 Sep 8. Neuroradiology. 2015. PMID: 26349479 Clinical Trial.

8

Soluble Urokinase Receptor and Chronic Kidney Disease.

Schumacher M, Wanner C, Beyersmann J. Schumacher M, et al. N Engl J Med. 2016 Mar 3;374(9):890. doi: 10.1056/NEJMc1515787. N Engl J Med. 2016. PMID: 26962916 No abstract available.

9

Adverse event development in clinical oncology trials.

Schmoor C, Bender R, Beyersmann J, Kieser M, Schumacher M. Schmoor C, et al. Among authors: schumacher m. Lancet Oncol. 2016 Jul;17(7):e263-e264. doi: 10.1016/S1470-2045(16)30223-6. Lancet Oncol. 2016. PMID: 27396638 No abstract available.

10

Competing risk bias was common in a prominent medical journal.

Schumacher M, Ohneberg K, Beyersmann J. Schumacher M, et al. J Clin Epidemiol. 2016 Dec;80:135-136. doi: 10.1016/j.jclinepi.2016.07.013. Epub 2016 Aug 1. J Clin Epidemiol. 2016. PMID: 27492787 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,967 results

Search Page